Guidelines and Statements

    AUGS and SUFU Release Release Frequently Asked Question (FAQ) documents for Patients and Providers on Mesh Midurethral Slings for Stress Urinary Incontinence
    March 12, 2014 – The American Urogynecologic Society (AUGS) and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU), jointly developed two Frequently Asked Question (FAQ) documents for you and your patients. Click on the below links to read the FAQ's.

    Frequently Asked Questions by Patients: Mid-urethral slings for Stress Urinary Incontinence

    Frequently Asked Questions by Providers: Mid-urethral slings for Stress Urinary Incontinence

    AUGS and SUFU Release Position Statement on Mesh Midurethral Slings (MUS) for Stress Urinary Incontinence
    January 6, 2014 – The American Urogynecologic Society (AUGS) and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU), jointly develop and release a position statement on Mesh Midurethral Slings (MUS) for Stress Urinary Incontinence. The statement strongly supports the use of the mid-urethral sling in the surgical management of stress urinary incontinence. Click here to read the position statement.

    AUGS Position Statement on the Restriction of Surgical Options for Pelvic Floor Disorders
    March 26, 2013 – The American Urogynecologic Society (AUGS) issued a position statement today strongly opposing restrictions that ban surgical options for the treatment of pelvic organ prolapse (POP), including transvaginal surgical mesh cleared for use by the U.S. Food and Drug Administration (FDA). Individualized treatment decisions should be made between patients and their surgeons, with the goal of providing the patient with the best, most effective therapy based on each patient’s specific clinical need. Click here to read the position statement.

    AUGS Releases Guidelines for Privileging and Credentialing Physicians for Sacrocolpopexy for Pelvic Organ Prolapse
    AUGS is pleased to announce the release of Guidelines for Privileging and Credentialing Physicians for Sacrocolpopexy for Pelvic Organ Prolapse (POP). The purpose of this guideline is to provide recommendations to assist health care institutions when considering granting privileges to perform sacrocolpopexy. Sacrocolpopexy for POP should be performed by surgeons with board certification or active candidacy for board certification in obstetrics and gynecology or urology who also have requisite knowledge, surgical skills, and experience in reconstructive pelvic surgery. This document provides guidelines for surgeons requesting new privileges to perform sacrocolpopexy as well as surgeons who currently have privileges and are requesting renewal. Click here to read the full Guidelines. You may also read the published guidelines in the March/April 2013 issue of Female Pelvic Medicine & Reconstructive Surgery.

    AUGS Releases Guidelines for Providing Privileges and Credentials to Physicians for Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse
    The adoption of new technology or procedures into a clinician’s surgical armamentarium is driven by multiple factors. Patient safety and anticipated long-term improvement in outcomes should be the primary objective that guides a surgeon’s decision to deliver care involving new procedures. Surgically complex procedures require a balance of knowledge, surgical skill, and experience, with appropriate ongoing surgical volume and monitoring of outcomes and adverse events. Transvaginal placement of surgical mesh for pelvic organ prolapse has the potential to improve quality of life and anatomic outcomes (especially in the anterior compartment), but also has potential serious adverse events as outlined by the FDA’s July 2011 Safety Communication. This document provides Guidelines for privileging and credentialing of physicians planning to implement or continue using this new technology in clinical practice. Click here to read full guidelines document.

    Urodynamic Testing before Stress Incontinence Surgery: An AUGS Position Statement
    AUGS members have made inquiries to the AUGS office on whether AUGS has a position on the Urinary Incontinence Treatment Network’s (UITN) recently published results of the Value of Urodynamic Evaluation (ValUE) trial. Click here to read statement from AUGS.

    AUGS and ACOG
    Joint Recommendations Issued on Use of Vaginal Mesh for POP (December, 2011)

    Urinary Incontinence Pocket Guide
    AUGS has an updated Urinary Incontinence Pocket Guide adapted with recommendations from the International Guidelines Center. The guide defines principles for high quality healthcare and is an excellent resource for medical providers. To order copies of the Pocket Guide for your practice, you may contact the International Guidelines Center via email at

    AUGS Statement on Urodynamic Testing
    The American Urogynecologic Society recognizes that urodynamic tests are diagnostic, not screening modalities, that may be used to determine the factors responsible for various urinary tract dysfunctions.

    AUGS Statement on Pelvic Floor Rehabilitation
    Pelvic floor rehabilitation therapy, including pelvic floor stimulation and biofeedback guided pelvic floor exercises, used alone or in combination, are a proven method used to treat symptoms of urinary incontinence and pelvic floor dysfunction.

    Position Statement on Standardization of Urodynamic Training in North America
    Background: Assuring the quality of urodynamic testing remains a central concern of health care providers offering care to patients with lower urinary tract disorders, patients themselves, and insurance organizations. The International Continence Society (ICS) now recommends standards for UDS training programs. The recommendations are for the training of beginners (both performing and interpreting) in the field. The draft recommendations, authored by Derek Griffiths, PhD, were presented at the 2002 Annual General Meeting of the ICS in Heidelberg, Germany, and have since been finalized and approved. The recommendations are available at the ICS Web site at

    Purpose of Statement: Urodynamics are a group of functional diagnostic studies evaluating the transport, storage and evacuation of urine by the lower urinary tract. These studies are invasive, costly and involve a significant learning curve for accurate performance and interpretation. The ICS is recognized as the world’s largest and most authoritative interdisciplinary society devoted to Urodynamics and lower urinary tract function. The ICS recommendations, as they are written, do not provide for testing of individuals and do not lead to any formal qualification or board certification. Therefore, the following organizations support standardized training programs meeting the ICS recommendations.

    Supporting Organizations:

    • Society of Urologic Nurses and Associates (SUNA) was established in 1972 and is a professional organization of nearly 3,000 members committed to excellence in clinical practice and research through education of its members, patients, families and community. SUNA’s vision is to be the nursing authority in the management of persons with urological healthcare concerns.
    • Society for Urodynamics and Female Urology (SUFU) was established in 1978 and fosters interdisciplinary dialogue and communication, promotion of the development of young scientists, and the development of scientific, educational, and professional activities through publications, meetings and original activities to assist in the establishment of standards of care. The purposes of this society are to improve the art and science of Urology through basic and applied clinical research in urodynamics and neurourology, voiding function and dysfunction, female urology and pelvic floor dysfunction.
    • The American Urogynecologic Society (AUGS) founded in 1979 to represent healthcare professional and scientists dedicated to improving the lives of women with pelvic floor disorders, such as pelvic prolapse and bowel and bladder control problems. By encouraging research and education, AUGS promotes the highest standards of practice in the prevention and treatment of these disorders in an ethical, safe and effective manner. AUGS recognizes UDS as diagnostic, not screening modalities, which may be used to determine the factors responsible for various urinary tract dysfunctions.

    Legal Disclaimer
    The information above is intended to provide patients and physicians with general information, and is not intended to substitute for the treating physician's clinical judgment. The treating physician should make all treatment decisions based upon his or her independent judgment and the patient's individual clinical presentation.

    American Urogynecologic Society
    2025 M Street NW, Suite 800
    Washington, DC 20036
    P: 202.367.1167    |    F: 202.367.2167
    Support the PFD Research Foundation

    As the leader in Female Pelvic Medicine and Reconstructive Surgery,
    AUGS promotes the highest quality patient care through excellence
    in education, research and advocacy.

    Contact Us    |    Privacy Policy    |    HONcode Accredited

    © 2013 American Urogynecologic Society. All rights reserved.